Literature DB >> 525908

Control of radiation-induced emesis with promethazine, cimetidine, thiethylperazine, or naloxone.

J R Cooper, J L Mattsson.   

Abstract

Promethazine (2 mg/kg), cimetidine (4 mg/kg), thiethylperazine (0.86 mg/kg), and naloxone (0.08 mg/kg) were each evaluated for their ability to increase the threshold of radiation-induced emesis in the dog. Each dog was fed a can of dog food (ca 0.4 kg) and then injected IM with the appropriate drug 1 hour before being irradiated by a 60Co teletherapy unit. The total radiation dose given an individual dog was determined by an up-and-down exposure schedule. Dogs were then observed continuously for 10 hours while the number, time of onset, and duration of each emetic episode were monitored. The dose of radiation causing emesis in 50% (ED50 +/- SEM) of control dogs was 170 +/- 38.5 rad. The ED50 +/- SEM was increased to 402 +/- 18.6 rad by promethazine, to 331 +/- 27.3 rad by cimetidine, and to 320 +/- 38.5 rad by thiethylperazine. This increased tolerance was significant at P less than 0.05 for each drug. The ED50 for naloxone was 262.5 +/- 92.9 rad, which was not a statistically significant increase in threshold.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 525908

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  3 in total

1.  Marked depression of radiation-induced emesis by olfactory bulbectomy or pre-exposure using low doses.

Authors:  Y Miyachi
Journal:  Experientia       Date:  1996-03-15

Review 2.  Signals for nausea and emesis: Implications for models of upper gastrointestinal diseases.

Authors:  Paul L R Andrews; Charles C Horn
Journal:  Auton Neurosci       Date:  2006-03-23       Impact factor: 3.145

3.  Ondansetron and promethazine have differential effects on hypothermic responses to lithium chloride administration and to provocative motion in rats.

Authors:  Drielle D Guimaraes; Paul L R Andrews; John A Rudd; Valdir A Braga; Eugene Nalivaiko
Journal:  Temperature (Austin)       Date:  2015-10-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.